Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Joint effect of visit-to-visit variability in LDL-cholesterol, HDL-cholesterol and HbA1c on cardiovascular and total mortality in patients with diabetes

Fig. 1

Stratified analyses by potential effect modifiers for the association between LDL-C CV and CVD mortality in various subgroups*. *Adjusted, if not stratified, for sex, glycemia treatment group, lipids treatment group, race, age, education, BMI, diabetes duration, systolic blood pressure (SBP), smoking and drinking status, estimated glomerular filtration rate (eGFR) at baseline, as well as mean of HbA1c, high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) during the first 2 years of follow-up

Back to article page